Submission of Audio recordings of Earnings Call for the quarter and nine months ended December 31, 2025
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has submitted the audio recording of its earnings call for the quarter and nine months ended December 31, 2025 to the stock exchanges (NSE/BSE). This is a routine compliance filing under SEBI's Listing Regulations, which requires companies to upload recordings of analyst/investor calls. The filing itself does not contain the financial details, but investors can listen to the recording for management commentary on Q3 FY26 performance. No specific numbers, guidance, or strategic updates are disclosed in this particular filing.
This is a procedural disclosure with no direct impact on the stock price. Investors interested in management's views on margins, growth outlook, and strategy should review the actual earnings call recording for actionable insights.